NVAX
NASDAQ
$8.08
Novavax Inc (NVAX)
Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company is headquartered in Gaithersburg, Maryland.
Sector:
Healthcare
Industry:
Biotechnology
Hold
Target: $14.11 (+74.74%)
Market Cap
$1.39B
Free Cash Flow Yield
-6.61%
Beta (5Y)
1.45
Price Chart
Valuation
Market Cap$1.39B
Forward P/E2.58
PEG1.32
P/S2.32
P/B41.23
Profitability
Total Revenue (TTM)$596M
Gross Profit (TTM)$164M
EBITDA-$55M
Profit Margin-6.8%
Operating Margin-11.1%
EPS-$0.54
Financial Health
Debt-to-Equity-201%
Free Cash Flow Yield-6.61%
Growth & Risk
EPS 5Y CAGR-42.97%
Revenue 5Y CAGR-8.30%
Beta (5Y)1.45
Sharpe Ratio0.49